News & Events

Expert shares advances and opportunities for genetic editing

November 8, 2018

Genome engineering was the subject of the day as Arizona State University’s Biodesign Institute kicked off a new lecture series designed to bring science’s preeminent thought leaders to ASU. The Arntzen Grand Challenges Lecture Series launched on Nov. 1 with a presentation by Samuel Sternberg, co-author of A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution—the premiere text on the emergence and future of genetic editing. CRISPR is a revolutionary tool...

Founding director of ASU’s Biodesign Institute, Charles Arntzen, retires

November 10, 2017

Arntzen's creative science leads to discovery of Ebola antidote   From his roots as a fair-haired Minnesota farm boy to climbing the ladder of success in big pharma to blazing a translational academic research path into life-saving therapies, Charles Arntzen has led one extraordinary life in science.  During the course of a prolific career, Arntzen and his collaborators have gained international recognition and helped burnish a special shine on ASU’s star with their dedicated...

Discovery's Desert Home

September 18, 2017

  Editor's note: The following story was featured in the February 15 print edition of the journal Nature.  The Biodesign Institute at Arizona State University was designed to foster multidisciplinary collaboration and solve the world’s great challenges. The results speak for themselves. William Graves came to the Biodesign Institute at Arizona State University (ASU) determined to change the world. The physicist had spent the past 13 years at the Massachusetts Institute of...

Is the world ready for another Ebola outbreak?

May 17, 2017

A new Ebola outbreak in remote areas of the Democratic Republic of Congo has some public health officials on guard for larger outbreaks to come, but Arizona State University’s Charles Arntzen, who played a crucial role in development of the Ebola therapeutic drug called ZMapp, says the current outbreak is small and there are a number of fledgling drugs that can be used to fight it and vaccinate the people in local areas. Q:  What do you know about the current Ebola outbreak in the...

11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics

August 18, 2016

Charles Arntzen, Ph.D., Interim Co-director, Biodesign Center for Infectious Diseases and Vaccinology to present a keynote on “Design and Production of Anti-Ebola Vaccines and Therapeutics” and Stephen Albert Johnston, Ph.D., Director, Biodesign Center for Innovations in Medicine, to present a keynote on “Progress Towards a Universal, Preventative Cancer Vaccine” >>Visit conference website 

Arntzen honored as inaugural 'Rodale 100' recipient

February 2, 2016

Rodale, Inc., a highly influential publisher of some of the most established health and wellness lifestyle brands including Prevention, Men's Health, Women's Health, and Runner's World, has honored ASU Regents' professor Charles Arntzen with its highest honor. Arntzen has been named to the inaugural Rodale 100 list, which celebrates those who share the Rodale, Inc. mission: to inspire health, healing, happiness and love in the world.  Charles...

Prominent scientists named to lead ASU Biodesign Institute Center for Infectious Diseases and Vaccinology

January 22, 2016

Charles Arntzen, a researcher who discovered a method for producing an Ebola treatment in a tobacco plant, and Cheryl Nickerson, a microbiologist who discovered that mechanical cues can globally reprogram how pathogens cause disease, have been named to lead the Biodesign Institute’s Center for Infectious Diseases and Vaccinology as interim co-directors. The Center for Infectious Diseases and Vaccinology, one of 15 research centers at the growing Biodesign Institute at Arizona State...

Arntzen named to National Academy of Inventors

December 23, 2015

Arizona State University Regents’ Professor and research scientist Charles Arntzen, Ph.D., has been named a Fellow of the National Academy of Inventors (NAI). Arntzen is a pioneer in plant biotechnology and the development of plant-based vaccines and therapeutics for human and animal disease prevention.  Referred to as “the godfather of pharming,” Arntzen is best known for playing a key role in developing ZMapp, the first successful treatment against the Ebola virus during the...

Norovirus: Get in the know

December 9, 2015

ASU expert discusses common stomach bug that is in the news once again Norovirus, the gastrointestinal sickness that causes severe discomfort, has stricken 200 people at a Seattle holiday party and is suspected in the illnesses of 80 in Boston, according to news reports. But don't dismiss it as mere food poisoning. The effects of norovirus are more far-reaching and can wield enormous economic damage from shutting down buildings to knocking employees out of work and even closing...

Midweek Mindtweak with Charles J. Arntzen

September 23, 2015

Charlie Arntzen sits down with local entrepreneurs to discuss creativity in science. RSVP